RESEARCH FIELD The Centryin of Attention 03/06/2019 | Jonathan James A novel protein platform helps neutralize powerful MRSA toxins. DISEASE AREA Grappling GK 03/07/2019 | Jonathan James How a new compound promises to selectively activate hepatic glucokinase in a bid to treat type 2 diabetes. OUTSIDE THE LAB Revolutionizing Medicine – While Learning “Novartian” 01/24/2019 | James Strachan Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania. DISEASE AREA Fighting the Flu 01/23/2019 | Jonathan James A screen of 2000 synthetic compounds has uncovered a novel agent against antiviral resistant influenza. This email was sent to {~email~} by info@email.thetranslationalscientist.com. To ensure delivery of emails to your inbox, please add info@email.thetranslationalscientist.com to your address book or safe sender list. To view online, please click here. Create or manage your account here Unsubscribe here The Translational Scientist (a brand of Texere Publishing Limited) Booths Park 1, Chelford Road, Knutsford, Cheshire, WA16 8GS, UK Registered Company Number: 08113419